HFE hemochromatosis: an overview about therapeutic recommendations

AUTOR(ES)

Cancado, Rodolfo D; Alvarenga, Aline Morgan; Santos, Paulo Caleb JL

FONTE

Hematology, Transfusion and Cell Therapy

DATA DE PUBLICAÇÃO

2022

RESUMO

Abstract Hemochromatosis is currently characterized by the iron overload caused by hepcidin deficiency. Large advances in the knowledge on the hemochromatosis pathophysiology have occurred due to a better understanding of the protein of the iron metabolism, the genetic basis of hemochromatosis and of other iron overload diseases or conditions which can lead to this phenotype. In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.

Documentos Relacionados

• Non-HFE hemochromatosis
• Overview of hemochromatosis.
• Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis
• Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding
• HFE gene knockout produces mouse model of hereditary hemochromatosis